Cargando…

Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison

BACKGROUND: Schistosomiasis is a neglected tropical disease, targeted by the World Health Organization for reduction in morbidity by 2020. It is caused by parasitic flukes that spread through contamination of local water sources. Traditional control focuses on mass drug administration, which kills t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collyer, Benjamin S., Turner, Hugo C., Hollingsworth, T. Déirdre, Keeling, Matt J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813092/ https://www.ncbi.nlm.nih.gov/pubmed/31647019 http://dx.doi.org/10.1186/s13071-019-3749-4

Ejemplares similares

Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration
por: Kura, Klodeta, et al.
Publicado: (2020)

SCHISTOX: An individual based model for the epidemiology and control of schistosomiasis
por: Graham, Matthew, et al.
Publicado: (2021)

Economic Evaluations of Mass Drug Administration: The Importance of Economies of Scale and Scope
por: Turner, Hugo C, et al.
Publicado: (2018)

The transmission dynamics of Strongyloides stercoralis and the impact of mass drug administration
por: Collyer, Benjamin S., et al.
Publicado: (2024)

Optimizing Delivery of Mass Drug Administration for Schistosomiasis
por: Friedman, Jennifer F.
Publicado: (2019)

A comparison of two mathematical models of the impact of mass drug administration on the transmission and control of schistosomiasis
por: Truscott, J.E., et al.
Publicado: (2017)

Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA)
por: Collyer, Benjamin S., et al.
Publicado: (2020)

Early lessons from schistosomiasis mass drug administration programs
por: Secor, W. Evan
Publicado: (2015)

Diagnosing risk factors alongside mass drug administration using serial diagnostic tests—which test first?
por: Dyson, Louise, et al.
Publicado: (2018)

The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths
por: Anderson, Roy, et al.
Publicado: (2014)

Measuring and modelling the effects of systematic non-adherence to mass drug administration
por: Dyson, Louise, et al.
Publicado: (2017)

The COUNTDOWN Study Protocol for Expansion of Mass Drug Administration Strategies against Schistosomiasis and Soil-Transmitted Helminthiasis in Ghana
por: Campbell, Suzy J., et al.
Publicado: (2018)

Probability distributions of helminth parasite burdens within the human host population following repeated rounds of mass drug administration and their impact on the transmission breakpoint
por: Collyer, Benjamin S., et al.
Publicado: (2021)

Efficacy of contact tracing for the containment of the 2019 novel coronavirus (COVID-19)
por: Keeling, Matt J, et al.
Publicado: (2020)

Uptake of Mass Drug Administration Programme for Schistosomiasis Control in Koome Islands, Central Uganda
por: Tuhebwe, Doreen, et al.
Publicado: (2015)

Mass drug administration and the sustainable control of schistosomiasis: an evaluation of treatment compliance in the rural Philippines
por: Inobaya, Marianette T., et al.
Publicado: (2018)

Mapping survey of schistosomiasis and soil-transmitted helminthiases towards mass drug administration in The Gambia
por: Camara, Yaya, et al.
Publicado: (2021)

How important is the spatial movement of people in attempts to eliminate the transmission of human helminth infections by mass drug administration?
por: Collyer, Benjamin S., et al.
Publicado: (2023)

Community perceptions of mass drug administration for soil-transmitted helminthiasis and schistosomiasis in selected schools in the Philippines
por: Lorenzo, Pauline Joy, et al.
Publicado: (2019)

Individual longitudinal compliance to neglected tropical disease mass drug administration programmes, a systematic review
por: Maddren, Rosie, et al.
Publicado: (2023)

Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
por: Kura, Klodeta, et al.
Publicado: (2021)

Persistent Hotspots in Schistosomiasis Consortium for Operational Research and Evaluation Studies for Gaining and Sustaining Control of Schistosomiasis after Four Years of Mass Drug Administration of Praziquantel
por: Kittur, Nupur, et al.
Publicado: (2019)

Current Understanding of Immunity Against Schistosomiasis: Impact on Vaccine and Drug Development
por: Molehin, Adebayo J
Publicado: (2020)

Cost and cost-effectiveness of soil-transmitted helminth treatment programmes: systematic review and research needs
por: Turner, Hugo C., et al.
Publicado: (2015)

The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
por: Kura, Klodeta, et al.
Publicado: (2020)

Impact of community-based integrated mass drug administration on schistosomiasis and soil-transmitted helminth prevalence in Togo
por: Bronzan, Rachel N., et al.
Publicado: (2018)

Schistosomiasis in School Age Children in Sierra Leone After 6 Years of Mass Drug Administration With Praziquantel
por: Bah, Yakuba M., et al.
Publicado: (2019)

Lessons Learned in Conducting Mass Drug Administration for Schistosomiasis Control and Measuring Coverage in an Operational Research Setting
por: Binder, Sue, et al.
Publicado: (2020)

What is the impact of acquired immunity on the transmission of schistosomiasis and the efficacy of current and planned mass drug administration programmes?
por: Kura, Klodeta, et al.
Publicado: (2021)

Costs of mass drug administration for scabies in Fiji
por: Mow, Maria, et al.
Publicado: (2022)

Pregnant Women’s Acceptance of Hypothetical Zika Vaccine
por: Alholm, Zachary, et al.
Publicado: (2017)

Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
por: Anderson, Roy M, et al.
Publicado: (2020)

Evaluation of integrated interventions layered on mass drug administration for urogenital schistosomiasis elimination: a cluster-randomised trial
por: Knopp, Stefanie, et al.
Publicado: (2019)

Informing antimicrobial stewardship with explainable AI
por: Cavallaro, Massimo, et al.
Publicado: (2023)

Morbidity Control of Schistosomiasis by Mass Drug Administration: How Can We Do It Best and What Will It Take to Move on to Elimination?
por: Colley, Daniel G.
Publicado: (2014)

Accuracy of Coverage Survey Recall following an Integrated Mass Drug Administration for Lymphatic Filariasis, Schistosomiasis, and Soil-Transmitted Helminthiasis
por: Budge, Philip J., et al.
Publicado: (2016)

Community perception of school-based mass drug administration program for soil-transmitted helminths and Schistosomiasis in Ogun State, Nigeria
por: Akinsolu, Folahanmi T., et al.
Publicado: (2023)

The Hypothetical Rabbit
por: Kattan, Michael W.
Publicado: (2016)

Comparison between one and two dose SARS-CoV-2 vaccine prioritization for a fixed number of vaccine doses
por: Hill, Edward M., et al.
Publicado: (2021)

An assessment of the vaccination of school-aged children in England against SARS-CoV-2
por: Keeling, Matt J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_le1vsct0bqi4vb7msl1uo42hif